Molecular and Biological Functions of Quercetin as a Natural Solution for Cardiovascular Disease Prevention and Treatment

[1]  A. Mureşan,et al.  Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat's heart. , 2018, Physiology international.

[2]  A. Adedapo,et al.  Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPAR&ggr; signaling pathways , 2018, BioFactors.

[3]  Yan-xia Jiang,et al.  Isoquercetin ameliorates myocardial infarction through anti-inflammation and anti-apoptosis factor and regulating TLR4-NF-κB signal pathway. , 2018, Molecular medicine reports.

[4]  Catalina Carrasco-Pozo,et al.  Quercetin Prevents Diastolic Dysfunction Induced by a High-Cholesterol Diet: Role of Oxidative Stress and Bioenergetics in Hyperglycemic Rats , 2018, Oxidative medicine and cellular longevity.

[5]  Xiangli Meng,et al.  Quercetin exerts cardiovascular protective effects in LPS-induced dysfunction in vivo by regulating inflammatory cytokine expression, NF-κB phosphorylation, and caspase activity , 2018, Molecular and Cellular Biochemistry.

[6]  M. Aggarwal,et al.  Integrative Medicine for Cardiovascular Disease and Prevention. , 2017, The Medical clinics of North America.

[7]  S. Yusuf,et al.  Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease , 2017, Circulation research.

[8]  D. Panagiotakos,et al.  Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel , 2017, Archives of medical science : AMS.

[9]  C. Lavie,et al.  Obesity and cardiovascular diseases. , 2017, Minerva medica.

[10]  P. Sudhakaran,et al.  Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-κB signaling pathway. , 2016, Cellular immunology.

[11]  S. Taleb.  Inflammation in atherosclerosis. , 2016, Archives of cardiovascular diseases.

[12]  I. Graham.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[13]  S. Bhaskar,et al.  Quercetin modulates toll-like receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats , 2016, Molecular and Cellular Biochemistry.

[14]  Xiujie Li,et al.  Protective Effect of Quercetin on Posttraumatic Cardiac Injury , 2016, Scientific Reports.

[15]  Y. Turkoz,et al.  Effect of chemotherapy exposure prior to pregnancy on fetal brain tissue and the potential protective role of quercetin , 2015, Cytotechnology.

[16]  Tsong-Ming Lu,et al.  Hypocholesterolemic Efficacy of Quercetin Rich Onion Juice in Healthy Mild Hypercholesterolemic Adults: A Pilot Study , 2015, Plant Foods for Human Nutrition.

[17]  R. Fimmers,et al.  Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial , 2015, British Journal of Nutrition.

[18]  S. Lindberg.  Prognostic utility of the soluble CD40 ligand in acute coronary syndrome. , 2014, Coronary artery disease.

[19]  J. Czepas,et al.  The flavonoid quercetin: possible solution for anthracycline-induced cardiotoxicity and multidrug resistance. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[20]  Mona F. Mahmoud,et al.  Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation , 2013, PloS one.

[21]  G. Rimbach,et al.  Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[22]  S. Milton Prabu,et al.  Quercetin potentially attenuates cadmium induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. , 2013, European review for medical and pharmacological sciences.

[23]  G Van Camp,et al.  Cardiovascular Disease Prevention , 2012 .

[24]  T. Kooistra,et al.  Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. , 2011, Atherosclerosis.

[25]  T. Kang,et al.  Quercetin Suppresses Cyclooxygenase-2 Expression and Angiogenesis through Inactivation of P300 Signaling , 2011, PloS one.

[26]  A. Tropeano,et al.  Do all antihypertensive drugs improve carotid intima‐media thickness?
A network meta‐analysis of randomized controlled trials , 2011, Fundamental & clinical pharmacology.

[27]  N. Benowitz,et al.  Impact of Smokeless Tobacco Products on Cardiovascular Disease: Implications for Policy, Prevention, and Treatment: A Policy Statement From the American Heart Association , 2010, Circulation.

[28]  J. O’Keefe,et al.  Primary and secondary prevention of cardiovascular diseases: a practical evidence-based approach. , 2009, Mayo Clinic proceedings.

[29]  J. Schrezenmeir,et al.  Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study , 2009, British Journal of Nutrition.

[30]  D. Hausman,et al.  Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. , 2008, Journal of medicinal food.

[31]  M. Yacoub,et al.  Modulated Inflammation by Injection of High-Mobility Group Box 1 Recovers Post-Infarction Chronically Failing Heart , 2008, Circulation.

[32]  Suna Kim,et al.  The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. , 2008, Biochemical and biophysical research communications.

[33]  G. Rimbach,et al.  Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. , 2008, The Journal of nutrition.

[34]  A. Bast,et al.  Health effects of quercetin: from antioxidant to nutraceutical. , 2008, European journal of pharmacology.

[35]  Jeong-Yeh Yang,et al.  Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. , 2008, Life sciences.

[36]  A. Barnett.  The importance of treating cardiometabolic risk factors in patients with type 2 diabetes , 2008, Diabetes & vascular disease research.

[37]  S. Litwin,et al.  Quercetin reduces blood pressure in hypertensive subjects. , 2007, The Journal of nutrition.

[38]  Christopher P Cannon,et al.  Diabetes and mortality following acute coronary syndromes. , 2007, JAMA.

[39]  Ming-Jiuan Wu,et al.  Distinctive Antioxidant and Antiinflammatory Effects of Flavonols , 2006 .

[40]  S. Girardin,et al.  Chronic inflammation: importance of NOD2 and NALP3 in interleukin‐1β generation , 2006 .

[41]  E. Kulinskaya,et al.  Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.

[42]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[43]  Peter Libby,et al.  Inflammation and cardiovascular disease mechanisms. , 2006, The American journal of clinical nutrition.

[44]  J. Lekakis,et al.  Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. , 2005 .

[45]  Tomás Perez-Acle,et al.  Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. , 2005, The Biochemical journal.

[46]  J. Lovegrove,et al.  Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen‐stimulated platelet activation pathway in humans , 2004, Journal of thrombosis and haemostasis : JTH.

[47]  J. Duarte,et al.  Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats , 2004, Molecular and Cellular Biochemistry.

[48]  Prakash Shetty,et al.  The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications , 2004, Public Health Nutrition.

[49]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[50]  Kim D Janda,et al.  Evidence for Ozone Formation in Human Atherosclerotic Arteries , 2003, Science.

[51]  F. Cambien,et al.  Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. , 2003, The New England journal of medicine.

[52]  George Kuriakose,et al.  The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages , 2003, Nature Cell Biology.

[53]  D. Stupack,et al.  Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli , 2003, Science.

[54]  J. Freedman.  CD40 ligand--assessing risk instead of damage? , 2003, The New England journal of medicine.

[55]  R Brian Haynes,et al.  Helping patients follow prescribed treatment: clinical applications. , 2002, JAMA.

[56]  L. Mosca.  C-reactive protein--to screen or not to screen? , 2002, The New England journal of medicine.

[57]  A. Friedman.  Renovascular hypertension, endothelial function, and oxidative stress. , 2002, The New England journal of medicine.

[58]  R. Califf,et al.  Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. , 2002, The New England journal of medicine.

[59]  E. van Nood,et al.  Flavonoids: a review of probable mechanisms of action and potential applications. , 2001, The American journal of clinical nutrition.

[60]  C. Manach,et al.  Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats. , 2001, The Journal of nutrition.

[61]  Christopher K. Glass,et al.  Atherosclerosis The Road Ahead , 2001, Cell.

[62]  J. Strain,et al.  Nonalcoholic red wine extract and quercetin inhibit LDL oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. , 2000, Clinical chemistry.

[63]  P. Kopelman.  Obesity as a medical problem , 2000, Nature.

[64]  G Williamson,et al.  Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β‐glucosidase activity , 1998, FEBS letters.

[65]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[66]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[67]  J. Gutteridge,et al.  Lipid peroxidation and antioxidants as biomarkers of tissue damage. , 1995, Clinical chemistry.

[68]  O. Texier,et al.  Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. , 1995, The Journal of nutrition.

[69]  Xinliang Yao,et al.  Quercetin attenuates high fructose feeding-induced atherosclerosis by suppressing inflammation and apoptosis via ROS-regulated PI3K/AKT signaling pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[70]  G. Oboh,et al.  Quercetin and Its Role in Chronic Diseases. , 2016, Advances in experimental medicine and biology.

[71]  M. Taskinen,et al.  ESC/EAS Guidelines for the Management of Dyslipidaemias , 2013 .

[72]  T. Jalili,et al.  Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. , 2012, Advances in nutrition.

[73]  P. Okunieff,et al.  Antioxidant properties of quercetin. , 2011, Advances in experimental medicine and biology.

[74]  Raymond J Carroll,et al.  Quercetin may suppress rat aberrant crypt foci formation by suppressing inflammatory mediators that influence proliferation and apoptosis. , 2009, The Journal of nutrition.

[75]  Gary Williamson,et al.  Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.

[76]  Jian‐Jun Li,et al.  Inflammation may be a bridge connecting hypertension and atherosclerosis. , 2005, Medical hypotheses.

[77]  T. Vree,et al.  Human Nutrition and Metabolism—Research Communication Bioavailabilities of Quercetin-3- Glucoside and Quercetin-4*- Glucoside Do Not Differ in Humans , 2000 .

[78]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[79]  E. Feskens,et al.  Dietary flavonoids and cancer risk in the Zutphen Elderly Study. , 1994, Nutrition and cancer.